RE
PFE icon

RBC Europe’s Pfizer PFE Stock Holding History

RBC Europe’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$8.83M Sell
168,345
-4,148
-2% -$211K 0.42% 35
2022
Q1 		$8.93M Buy
172,493
+244
+0.1% +$12.7K 0.36% 37
2021
Q4 		$10.2M Sell
172,249
-232,274
-57% -$11.5M 0.45% 35
2021
Q3 		$17.4M Buy
404,523
+8,484
+2% +$376K 0.71% 28
2021
Q2 		$15.5M Buy
396,039
+180,303
+84% +$7.01M 0.7% 28
2021
Q1 		$7.82M Sell
215,736
-5,101
-2% -$181K 0.42% 36
2020
Q4 		$8.13M Sell
220,837
-8,079
-4% -$296K 0.47% 36
2020
Q3 		$7.97M Sell
228,916
-16,145
-7% -$566K 0.53% 33
2020
Q2 		$7.6M Sell
245,061
-8,456
-3% -$287K 0.59% 30
2020
Q1 		$7.85M Sell
253,517
-15,328
-6% -$522K 0.78% 22
2019
Q4 		$9.99M Sell
268,845
-5,438
-2% -$194K 0.88% 22
2019
Q3 		$9.35M Sell
274,283
-9,061
-3% -$329K 0.92% 20
2019
Q2 		$11.6M Sell
283,344
-4,189
-1% -$166K 1.16% 17
2019
Q1 		$11.6M Sell
287,533
-16,631
-5% -$666K 1.28% 16
2018
Q4 		$12.6M Sell
304,164
-5,045
-2% -$209K 1.64% 11
2018
Q3 		$12.9M Buy
309,209
+11,540
+4% +$444K 1.43% 14
2018
Q2 		$10.2M Sell
297,669
-2,039
-0.7% -$69.7K 1.2% 19
2018
Q1 		$10.1M Buy
299,708
+1,459
+0.5% +$50.2K 1.23% 17
2017
Q4 		$10.2M Buy
298,249
+463
+0.2% +$15.8K 1.26% 19
2017
Q3 		$10.1M Buy
+297,786
New +$9.57M 1.32% 19

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RBC Europe's PFE Position: Q2 2022 in Review

RBC Europe reduced its Pfizer (PFE) stake by 2.4% in Q2 2022, selling an estimated $211K and leaving 168,345 shares worth $8.83M. The position accounts for 0.42% of the portfolio, ranked #35.

RBC Europe first reported a position in PFE in Q3 2017 and has held it in 20 quarters since. The position peaked at $17.4M in Q3 2021. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • RBC Europe held 168,345 shares of Pfizer worth $8.83M as of Q2 2022.
  • RBC Europe sold 4,148 Pfizer shares in Q2 2022, an estimated $211K.
  • Pfizer made up 0.42% of RBC Europe's portfolio in Q2 2022, its #35 holding.
  • RBC Europe first reported a position in Pfizer in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Pfizer position peaked at $17.4M in Q3 2021.
  • 3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.